【24h】

Diagnostic cerebral angiography: archaic and complication-prone or here to stay for another 80 years?

机译:诊断性脑血管造影:古老且易发并发症,还是要在这里再住80年?

获取原文
获取原文并翻译 | 示例
           

摘要

Cerebral angiography has for decades been of inestimable value in the diagnosis and evaluation of diseases of the CNS, particularlyfor vascular lesions such as aneurysms, arteriovenous malformations (AVMs) and fistulas (AVFs), CNS vasculitis, and atherosclerotic vascular disease. It has been nothing less than essential in the evaluation and treatment planning of these diseases, and it has furthered our understanding of the nature of these disease processes. However, catheter angiography remains an invasive procedure, albeit "minimally" so, involving the "unnatural" placement of catheters in very important and sometimes sensitive arteries. There is no way to entirely eliminate risk to these arteries and to the brain from this procedure, and the angiographer ponders primum non nocere when describing risk of stroke or death to the patient during the informed consent process. The focus of this review is the ongoing question: In the setting of constantly improving, utterly noninvasive CT angiography (CTA) and MR angiography (MRA) capabilities, is diagnostic cerebral angiography a brutish test of the past?
机译:数十年来,脑血管造影在中枢神经系统疾病的诊断和评估中具有不可估量的价值,特别是对于诸如动脉瘤,动静脉畸形(AVM)和瘘管(AVF)的血管病变,中枢神经系统血管炎和动脉粥样硬化性血管疾病。在这些疾病的评估和治疗计划中,这无非是必不可少的,它进一步加深了我们对这些疾病过程本质的理解。然而,导管血管造影术尽管是“最小”的,仍是一种侵入性手术,涉及在非常重要且有时是敏感的动脉中导管的“非自然”放置。这种方法无法完全消除这些动脉和大脑的风险,而血管造影师在描述知情同意过程中患者发生中风或死亡的风险时会考虑初发。这篇综述的重点是一个持续存在的问题:在不断提高,完全无创的CT血管造影(CTA)和MR血管造影(MRA)能力的背景下,诊断性脑血管造影是否是过去的残酷考验?

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号